Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal–bolus regimens: insights from the PREDICTIVE study

By Hermansen Kjeld   Dornhorst Anne   Sreenan Seamus  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2601-2608

Informa Healthcare

Access to resources Recommend Favorite

Therapeutically interchangeable? A study of real‐world outcomes associated with switching basal insulin analogues among US patients with type 2 diabetes mellitus using electronic medical records data

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 3, 2015-03 ,pp. : 245-253

John Wiley & Sons Inc

Access to resources Recommend Favorite

The glycemic efficacies of insulin analogue regimens according to baseline glycemic status in Korean patients with type 2 diabetes: sub‐analysis from the A1chieve® study

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 68, Iss. 11, 2014-11 ,pp. : 1338-1344

John Wiley & Sons Inc

Access to resources Recommend Favorite

Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study

By Liebl A.   Breitscheidel L.   Nicolay C.   Happich M.  

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2349-2358

Informa Healthcare

Access to resources Recommend Favorite

Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy

By Abrahamson Martin J.   Peters Anne  

Annals of Medicine, Vol. 44, Iss. 8, 2012-12 ,pp. : 836-846

Informa Healthcare

Access to resources Recommend Favorite